SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing a parabolic rally driven by its extremely low float and intense short-squeeze dynamics, with traders heavily focused on the stock's lack of available shares to borrow and astronomical borrow rates. While bulls are celebrating life-changing gains and pushing for triple-digit targets, many community members are expressing caution, citing the company's history of frequent reverse splits and ongoing dilution concerns as red flags.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility as investors react to a massive earnings beat and strong forward guidance by engaging in profit-taking after a historic year-long rally. The community is sharply divided, with bulls pointing to the company's robust AI-driven data center growth and share buyback program as proof of long-term value, while bears are focused on potential overvaluation and the risk of a broader cyclical slowdown in the memory sector.

The White Alien has arrived. The countdown to domination starts now.

The White Alien

The White Alien is generating buzz through aggressive social media cross-promotion with various other memecoins, sparking intense community debate between optimistic traders betting on rapid price momentum and skeptics questioning the token's long-term legitimacy.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending following a double earnings beat that topped analyst expectations, signaling a potential sentiment shift for the broader SaaS sector. While some community members are skeptical of a lasting turnaround, many are actively discussing a rotation back into high-growth software as the company leans into AI integration to drive future revenue.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is currently experiencing extreme volatility and heavy volume as traders react to a recent preclinical milestone payment and an upcoming R&D presentation, while others express deep skepticism regarding the company's long-term performance and potential reverse split. The community is sharply divided, with bulls pointing to fundamental technology developments and Big Pharma partnerships, while bears highlight persistent dilution, management concerns, and a downward trend in share price.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending due to community anticipation surrounding the latest monthly Binance token burn, which investors believe will reduce supply and drive upward price momentum. Proponents are actively discussing long-term recovery goals and the potential for a supply shock, while skeptical traders continue to debate the project's viability following its historic market collapse.

NEOS ETF Trust - NEOS Nasdaq 100 High Income ETF

NEOS Nasdaq 100 High Income ETF

Investors are actively debating the merits of the NEOS Nasdaq 100 High Income ETF (QQQI), frequently comparing its tax-efficient return-of-capital structure and monthly distribution reliability against other income-focused holdings like JEPQ, SPYI, and SCHD. The community is focused on evaluating these ETFs as long-term income generators for retirement, with a particular emphasis on whether their covered call strategies provide better risk-adjusted returns and capital preservation compared to traditional growth indices.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is currently trending as investors weigh mixed chart signals against robust institutional inflows, with the community actively debating whether to treat the asset as a bottoming opportunity or a risk-heavy proxy prone to volatility. Discussions are centered on critical technical thresholds, option market positioning, and the broader impact of institutional accumulation on Bitcoin's long-term price trajectory.

Alchemy Pay

Alchemy Pay is capturing significant community attention as investors debate its transition toward a Layer 1 blockchain and expansion of its fiat-to-crypto payment infrastructure. While some traders are bullish on new regulatory licensing and upcoming mainnet developments, others are actively debating concerns regarding token supply inflation and the project's long-term competitive moat against other payment solutions.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending as the stock undergoes a sharp re-rating alongside the broader software sector, with community discourse dominated by the 'SaaSpocalypse' narrative and conflicting views on whether AI serves as a long-term catalyst or an existential threat to its core business. Investors are closely monitoring the impact of aggressive share buybacks against shifting sentiment as the stock tests significant support levels amid heavy volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pfizer (NYSE:PFE) Trading 1.8% Higher - Should You Buy?

Pfizer (NYSE:PFE) Trading Up 1.8% - What's Next...

The Vaccine Safety Signal The Media Still Won't Read

The Vaccine Safety Signal The Media Still Won't Read Authored by Dr. Joseph Fraiman via the Brownstone Institute, The serious-adverse-event signal found in the Pfizer and Moderna mRNA Covid-19...

Pfizer Just Scored a Win That Wall Street Can't Ignore

Key PointsPfizer persuaded three drugmakers to delay the production of generic Vyndamax...

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings

Pfizer sees mixed Q1 signals as growth in key drugs offsets COVID declines. Can pipeline strength and M&A bets support long-term upside?

World Investment Advisors Acquires 40,239 Shares of Pfizer Inc. $PFE

World Investment Advisors boosted its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 11.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 397,952 shares of the biopharmaceutical company's stock afte...

Goldman Sachs resets Pfizer stock forecast

Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own, and Goldman Sachs appears to be asking for more proof before getting more...

BMY's Q1 Earnings Top Estimates, Breyanzi, Camzyos Drive Sales

Bristol-Myers beats Q1 estimates as strong Growth Portfolio sales and Eliquis demand offset legacy drug declines.

Ahead of Pfizer (PFE) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Get a deeper insight into the potential performance of Pfizer (PFE) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Eli Lilly (LLY) Beats Q1 Earnings and Revenue Estimates

Lilly (LLY) delivered earnings and revenue surprises of +21.06% and +12.37%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study

Pfizer reports Phase 3 data showing ELREXFIO improved progression-free survival versus standard therapy in multiple myeloma study.read more...

This account has been verified as an official PFE representative.

Verified Account

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

PFE
Pfizer Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PFE News

PFEPfizer Inc